TellBio

TellBio is a biotechnology company in the development stage, headquartered in Beverly, Massachusetts. Its goal is to revolutionize cancer detection and treatment through its unique and proprietary circulating tumor cell (CTC) technology as well as complementary therapeutic platforms TellDx and TellRx. TellBio's vision is to liberate patients and their families from cancer through its TellDx and TellRx platforms.TellDx is a fully functional diagnostic solution designed to detect live CTCs in liquid biopsies of patients. TellRx is a therapeutic platform that generates novel anti-cancer drugs by specifically targeting CTCs. The synergy of these platforms provides TellBio with a unique opportunity to detect CTCs through a first-class microfluidic diagnostic platform and target CTCs using innovative therapeutic approaches to improve outcomes for cancer patients.